Pentec Health
An industry leader for more than 30 years, Pentec Health provides patient-specific compounded sterile medications for administration in dialysis centers, as well as provides in-home Specialty Infusion services and complex pharmaceutical products to patients who require access outside of a hospital setting.
Pentec was named one of the fastest growing companies in the Philadelphia region for 7th year in a row as part of the 2017 Philadelphia 100® Awards. In 2018, Pentec also made the Inc. 5000 List for the 9th year in a row.
NEP sold Pentec Health to Wellspring Capital in October 2021.